openPR Logo
Press release

Cathepsin Inhibitors Market: Presence Of Novel Products In The Pipeline Is Expected To Significantly Support Growth By 2026 With Top Players F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp., Virobay Inc., LEO Pharma

02-25-2019 01:41 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Cathepsin Inhibitors

Cathepsin Inhibitors

Cathepsins are a group of lysosomal proteases (enzymes that degrades protein), found in all animals and other organisms, and perform a key role in cellular protein turnover. Cathepsin family includes serine proteases, aspartic proteases, and cysteine proteases. The aspartyl protease class is composed of cathepsins D and E. The cysteine protease class comprises cathepsins B, L, H, K, S, and O. Cathepsin G includes serine protease class. Currently, there are no approved cathepsin inhibitors in the market, however various research and development activities are under process for the development of novel cathepsin inhibitors for treatment of various conditions such as cancer, traumatic brain injury, Ebola infection, and others.

Download PDF Brochure of This Business Research Report :

Cathepsin Inhibitors Market Drivers

Various key players in the market are conducting clinical trials to gain approval for cathepsin inhibitors, which are under development phase and are expected to gain approval in the near future. For instance, Merck Sharp & Dohme Corp.’s product, Odanacatib, also known as MK-0822, is under Phase 2 clinical trial. MK-0822 is a cathepsin K inhibitor under development for the treatment of postmenopausal women with osteoporosis. Hence, presence of novel products in the pipeline is expected to significantly support growth of the cathepsin inhibitors market during the forecast period.

Furthermore, high prevalence of diseases for which cathepsin inhibitors are being developed may rise demand for such novel treatment approaches in the near future. For instance, according to the data published by Centers of Disease Control and Prevention in 2017, traumatic brain injury (TBI) is a major cause of death and disability in the U.S. TBIs contribute to about 30% of all injury deaths. 153 people in the U.S. die per day, from injuries that include TBI.

Cathepsin Inhibitors Market Regional Analysis

North America cathepsin inhibitors market is expected to hold a dominant position in the global cathepsin inhibitors market, owing to the high prevalence of disease such as cancer, which will increase demand for novel cancer treatment approaches such as cathepsin inhibitors in region.

For instance, according to the data published by National Cancer Institute, it was estimated that in 2018, around 1,735,350 new cases of cancer will be diagnosed in the U.S. and around 609,640 people will die from the disease.

Europe cathepsin inhibitors market is also expected to show a significant growth during the forecast period, owing to frequent research and development activities by key players for the development of new cathepsin inhibitors in the region. For instance, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, is developing RO5459072, a cathepsin S inhibitor, on the immune response to a gluten challenge in volunteers with celiac disease.

Cathepsin Inhibitors Market Key Players

Key players operating in global cathepsin inhibitors market include F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp., Virobay Inc., LEO Pharma, and others.

Else, Place an Enquiry To Talk With Our Analyst :

Cathepsin Inhibitors Market Taxonomy:

The global cathepsin inhibitors market is segmented on the basis of product type, indication, distribution channel, and region

By Product Type- Cathepsin S Inhibitors, Cathepsin K Inhibitors, Cathepsin B Inhibitors, Cathepsin L Inhibitors, Others.
By Indication- Cancer, Traumatic Brain Injury, Ebola Infection, Others.
By Distribution Channel- Hospitals Pharmacies, Retail Pharmacies, Online pharmacies.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cathepsin Inhibitors Market: Presence Of Novel Products In The Pipeline Is Expected To Significantly Support Growth By 2026 With Top Players F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp., Virobay Inc., LEO Pharma here

News-ID: 1614244 • Views: 570

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases

More Releases for Cathepsin

Anti-Cathepsin B Industry Landscape and its Growth Prospect By 2020-2030
Anti-Cathepsin B Market: Introduction Cathepsin B belongs to a family of lysosomal cysteine proteases. It plays an important role in intracellular proteolysis. In humans, Cathepsin B is encoded by the CTSB gene. Anti-Cathepsin B antibody is used to treat cancers, traumatic brain injuries, Ebola infection, and fertility issues. Report Overview: Key Drivers and Restraints of Global Anti-Cathepsin B Market •Rise in incidence rate of cancer across the globe is a major
Anti-Cathepsin B Market Seeking Growth from Emerging Markets, Views Sought On Ne …
The Anti-Cathepsin B Market report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Anti-Cathepsin B Market. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.The trends and expected prospects for
Anti-Cathepsin B Market to receive overwhelming hike in Revenues by 2029
Global Anti-Cathepsin B Market: Overview Cathepsin B is an important mediator of inflammation and programmed cell death in individual cells. It has a role in inducing cell dissolution and recycling of cellular organelles. This organic molecule has been implicated in various cancers and other chronic conditions like Alzheimer’s disease and seizures, being primarily involved in the diminution of memory with progress of disease. Anti-Cathepsin B molecules are antibodies against Cathepsin B,
Cathepsin K Inhibitors Therapeutics Pipeline Analysis 2019
Cathepsin K is a protease enzyme which is coded by CTSK gene. The function associated with the gene involves bone remodelling and resorption. Cathepsin K is a member of peptidase C1 protein family and expressed mainly in osteoclasts. Make enquiry before purchase @ The protein has high specificity for kinins and has the capability to catabolize collagen, elastin, and gelatin. Cathepsin K is found to be over-expressed in cancer such
Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC Revi …
A new report on “Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC Review, H2 2017” offers information on the different clinical stages of Cathepsin B. The report, added to the vast repository of Market Research Hub (MRH) offers information and insights on the current scenario in development of Cathepsin B. A comprehensive source of information, the report provides detailed insights on the factors that are likely
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC Mar …
"The Latest Research Report Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" About Cathepsin L1 Market According to the recently published report 'Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC Review, H2 2017'; Cathepsin L1 (Cathepsin L or Major Excreted Protein or